TR201619953A2 - Topi̇kal terapöti̇k formülasyonlar - Google Patents

Topi̇kal terapöti̇k formülasyonlar Download PDF

Info

Publication number
TR201619953A2
TR201619953A2 TR2016/19953A TR201619953A TR201619953A2 TR 201619953 A2 TR201619953 A2 TR 201619953A2 TR 2016/19953 A TR2016/19953 A TR 2016/19953A TR 201619953 A TR201619953 A TR 201619953A TR 201619953 A2 TR201619953 A2 TR 201619953A2
Authority
TR
Turkey
Prior art keywords
therapeutic formulations
topical therapeutic
present
acne
acne vulgaris
Prior art date
Application number
TR2016/19953A
Other languages
English (en)
Inventor
Karaağaç Bülent
Original Assignee
Buelent Karaagac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Buelent Karaagac filed Critical Buelent Karaagac
Priority to TR2016/19953A priority Critical patent/TR201619953A2/tr
Publication of TR201619953A2 publication Critical patent/TR201619953A2/tr

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Mevcut buluş; akne, akne vulgaris, inflamatuar lezyonların eşlik ettiği hafif ve orta şiddetli akne vulgaris, cilt ve yumuşak doku enfeksiyonlarının semptomatik ve/veya terapötik tedavisinde kullanılmak üzere, antibiyotik özellikteki uygun etken madde ve/veya farmasötik olarak kabul edilebilir türevlerinin monoterapi olarak tek başına kullanıldığı veya bu etken maddenin antibakteriyel özellikteki uygun aktif ajan/lar ile kombine tedavi olarak kullanıldığı farmasötik bileşim/ler ile ilgilidir.
TR2016/19953A 2016-12-28 2016-12-28 Topi̇kal terapöti̇k formülasyonlar TR201619953A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2016/19953A TR201619953A2 (tr) 2016-12-28 2016-12-28 Topi̇kal terapöti̇k formülasyonlar

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2016/19953A TR201619953A2 (tr) 2016-12-28 2016-12-28 Topi̇kal terapöti̇k formülasyonlar

Publications (1)

Publication Number Publication Date
TR201619953A2 true TR201619953A2 (tr) 2018-07-23

Family

ID=64901751

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2016/19953A TR201619953A2 (tr) 2016-12-28 2016-12-28 Topi̇kal terapöti̇k formülasyonlar

Country Status (1)

Country Link
TR (1) TR201619953A2 (tr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020133361A1 (en) * 2018-12-29 2020-07-02 L'oreal Kit for caring for the skin

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020133361A1 (en) * 2018-12-29 2020-07-02 L'oreal Kit for caring for the skin
CN113194908A (zh) * 2018-12-29 2021-07-30 莱雅公司 用于护理皮肤的套装

Similar Documents

Publication Publication Date Title
MX2021004546A (es) Composiciones de suministro de farmaco implantables y metodos de uso de las mismas.
CU20150163A7 (es) DERIVADOS DE 5-HETEROARIL-4-FENIL-4,5-DIHIDROPIRROLO(3,4-c)PIRAZOL-6-ONA ACTIVOS COMO INHIBIDORES DE BET
MX2020008258A (es) Formulaciones pediátricas de niraparib y métodos de tratamiento pediátricos.
BR112020019875A8 (pt) composições tópicas para alívio da dor
BR112018015718A2 (pt) utilização de estimuladores de sgc para o tratamento de esteato-hepatite não alcoólica (nash)
BR112016000335A8 (pt) método de tratamento da rosácea papulopustular, de tratamento de lesões inflamatórias da rosácea papulopustular e uso de uma composição farmacêutica
BR112015030315A2 (pt) derivado de 4-alquinilimidazol e medicamento compreendendo o mesmo como ingrediente ativo
MX2018002732A (es) Composicion y dispositivo medico que comprenden acido acetilsalicilico para el tratamiento de infecciones cutaneas por virus de papiloma humano.
BR112021016296A2 (pt) Formulações tópicas de rapamicina e seu uso em tratamento de angiofibromas faciais e outros distúrbios de pele
MX2019008544A (es) Nueva formulacion estable para anticuerpos anti-fxia.
SA519410993B1 (ar) النشاط المضاد للبكتيريا لأوليجو سكاريد من جالاكتو وزيليتول في العلاجات الجلدية
CL2018000430A1 (es) Compuesto de hidroxitriazina y uso médico relacionado.
MX2020006309A (es) Fórmulaciones de parasiticida de isoxazolina y métodos para el tratamiento de la blefaritis.
CY1125075T1 (el) Εκχυλισμα salvia haenkei σαν δραστικος παραγοντας στις διαδικασιες επανεπιθηλιωσης και επουλωσης ιστων
MX2018000262A (es) Usos terapeuticos de formulaciones de berberina.
MX2019008115A (es) Formulaciones topicas de detomidina.
BR112019007863A2 (pt) derivados de naftiridinona inovadores e seu uso no tratamento de arritmia
TR201619953A2 (tr) Topi̇kal terapöti̇k formülasyonlar
CL2020001791A1 (es) Composiciones farmacéuticas para la piel tópicas que contienen cerdulatinib y usos de estas.
MX2018011539A (es) Tratamiento de dolencias y enfermedades cutaneas asociadas a biopeliculas microbianas.
WO2015063613A3 (en) Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
ECSP22089498A (es) Inhibidores de il4i1 y métodos de uso
WO2016063265A3 (pt) Formulação tópica para o tratamento de infeções na pele ou mucosas, método de preparação e seus usos
MX2019011951A (es) Secretoma bacteriano para usarse en el tratamiento contra lesiones cutaneas.
AR108793A1 (es) Composiciones que comprenden timolol y un agente antiinflamatorio